Purpose To investigate the association between the use of topical β-blockers and
subsequent asthma attacks in glaucoma patients with asthma. Methods This was a …

Background/aims: Topical β antagonists are prescribed for glaucoma in approximately 500
000 people in the United Kingdom. The authors have previously shown that topical β …

Objective To determine if topical beta-blocker use is associated with increased risks of
cardiovascular and respiratory diseases in patients with glaucoma. Setting A retrospective …

Purpose: To investigate the use of topical ocular anti-glaucoma medications by
glaucomatous patients with obstructive pulmonary disease and their effect on related …

Aims To measure the prevalence of beta‐blocker eye drop prescribing and respiratory effect
of ocular beta‐blocker administration in people with asthma. Methods We measured the …

Introduction: Patients with asthma often have important co-morbidities which reduce the
likelihood of gaining optimal asthma control. Beta2-blockers are commonly prescribed for …

Background Asthma and chronic obstructive pulmonary disease (COPD), defined as
obstructive airways disease (OAD), are two common chronic conditions especially in the …

Introduction Few studies have examined outcomes and potential complications among
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …

Objectives: Topical β-blockers are contraindicated in obstructive pulmonary diseases
(OPDs). In this study we aimed to evaluate through central or local electronic medical …

We conducted a case-control study to measure the risk of pulmonary side effects following
the use of topical glaucoma medications, particularly the [beta] blockers, and to identify …